Skip navigation


Keep up to date on AgNovos news

Corporate Rebranding Announcement

AgNovos Healthcare announced today that it is rebranding itself as AgNovos Bioscience. The change in the name better reflects the Company’s mission to develop and commercialize new therapies that leverage proprietary, bone-building technology and regenerative medicine to address unmet needs in the treatment of bone disease.

“Renaming the Company AgNovos Bioscience reflects our focus on therapies that leverage regenerative medicine,” commented Tanner Howe, CEO. He continued, “While our name has changed, we remain consistent in our commitment to helping patients maintain or enhance their mobility, independence, and quality of life. We have made significant progress on our clinical and commercial programs, reaching the milestone of 200 procedures. Given this increase in the visibility of the Company and its products, the time is right to clarify our mission and vision.”

The comprehensive rebranding includes updates to the Company logo and digital presence.